1.7-thyroxine derivatives, substituted in 1n by heteromorphic carbohydramine, FGFR4 inhibitors; intermediates; pharmacological synthesis; pharmacological binding; and use as CCER therapy.

摘要

p Ring compounds derived from BIC & amp; merged with piridilo CLICO, intermediaries fgfr4 inhibitors; Compounds; Pharmaceutical composition, Pharmaceutical Combination; and its use for the treatment of cancer / p